Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
02 02 2021
Historique:
received: 16 08 2020
accepted: 08 01 2021
entrez: 2 2 2021
pubmed: 3 2 2021
medline: 3 2 2022
Statut: epublish

Résumé

Heart failure is a major public health problem, and abnormal iron metabolism is common in patients with heart failure. Although iron is necessary for metabolic homeostasis, it induces a programmed necrosis. Iron release from ferritin storage is through nuclear receptor coactivator 4 (NCOA4)-mediated autophagic degradation, known as ferritinophagy. However, the role of ferritinophagy in the stressed heart remains unclear. Deletion of

Identifiants

pubmed: 33526170
doi: 10.7554/eLife.62174
pii: 62174
pmc: PMC7853718
doi:
pii:

Substances chimiques

Cyclohexylamines 0
NcoA4 protein, mouse 0
Nuclear Receptor Coactivators 0
Phenylenediamines 0
ferrostatin-1 0
Ferritins 9007-73-2
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : British Heart Foundation
ID : RE/13/2/30182
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/11/3/29051
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1999001/11735
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/16/15/32294
Pays : United Kingdom

Informations de copyright

© 2021, Ito et al.

Déclaration de conflit d'intérêts

JI, SO, MR, HU, TM, YT, HA, KN, MA, MT, KN, AS, KO No competing interests declared

Références

Heart Vessels. 2004 Sep;19(5):237-41
pubmed: 15372299
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Am Chem Soc. 2014 Mar 26;136(12):4551-6
pubmed: 24592866
Trends Cardiovasc Med. 2007 Feb;17(2):48-54
pubmed: 17292046
Mol Cell Biol. 2004 Dec;24(24):10611-20
pubmed: 15572667
Front Biosci. 2007 Jan 01;12:874-82
pubmed: 17127344
JACC Basic Transl Sci. 2020 Mar 23;5(3):300-313
pubmed: 32215351
Annu Rev Physiol. 2010;72:19-44
pubmed: 20148665
Mol Cell Biol. 2019 Jun 27;39(14):
pubmed: 31061094
Redox Biol. 2020 Jan;28:101328
pubmed: 31574461
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16836-41
pubmed: 25385600
Cell Rep. 2016 Jan 26;14(3):411-421
pubmed: 26776506
Circulation. 2020 Feb 25;141(8):667-677
pubmed: 31931613
Nat Commun. 2019 Jul 17;10(1):3145
pubmed: 31316058
Biochim Biophys Acta. 2009 Jul;1790(7):589-99
pubmed: 18929623
Nature. 2014 May 1;509(7498):105-9
pubmed: 24695223
Eur Heart J. 2017 Feb 1;38(5):362-372
pubmed: 27545647
Lancet. 2011 Aug 20;378(9792):704-12
pubmed: 21856484
Nat Cell Biol. 2014 Nov;16(11):1069-79
pubmed: 25327288
Cell. 2014 Jan 16;156(1-2):317-331
pubmed: 24439385
J Am Heart Assoc. 2015 Jul 31;4(8):e002272
pubmed: 26231844
Nature. 2012 May 10;485(7397):251-5
pubmed: 22535248
Free Radic Biol Med. 2019 Apr;134:445-457
pubmed: 30731113
Nat Cell Biol. 2014 Dec;16(12):1180-91
pubmed: 25402683
J Mol Cell Cardiol. 2009 Jan;46(1):59-66
pubmed: 18992754
Mol Cell. 2015 Jul 16;59(2):298-308
pubmed: 26166707
Mol Psychiatry. 2017 Nov;22(11):1520-1530
pubmed: 28886009
Circ Res. 2020 Jul 31;127(4):486-501
pubmed: 32349646
Biochim Biophys Acta. 2012 Sep;1823(9):1468-83
pubmed: 22610083
Metallomics. 2014 Apr;6(4):748-73
pubmed: 24549403
N Engl J Med. 2009 Dec 17;361(25):2436-48
pubmed: 19920054
Annu Rev Physiol. 2007;69:69-85
pubmed: 17014365
Cell Death Dis. 2020 Feb 3;11(2):88
pubmed: 32015325
Oxid Med Cell Longev. 2014;2014:360438
pubmed: 24999379
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2672-2680
pubmed: 30692261
Curr Opin Cardiol. 2020 Mar;35(2):133-137
pubmed: 31904605
Toxicol Appl Pharmacol. 2005 Jan 15;202(2):199-211
pubmed: 15629195
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
J Mol Cell Cardiol. 2018 Jan;114:93-104
pubmed: 29129702

Auteurs

Jumpei Ito (J)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.
Department of Pharmacology, Faculty of Medicine, Osaka Medical College, Osaka, Japan.

Shigemiki Omiya (S)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Mara-Camelia Rusu (MC)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Hiromichi Ueda (H)

Department of Cardiovascular Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Tomokazu Murakawa (T)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Yohei Tanada (Y)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Hajime Abe (H)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Kazuki Nakahara (K)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Michio Asahi (M)

Department of Pharmacology, Faculty of Medicine, Osaka Medical College, Osaka, Japan.

Manabu Taneike (M)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.
Department of Cardiovascular Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Kazuhiko Nishida (K)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Ajay M Shah (AM)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Kinya Otsu (K)

The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH